Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness ZY Zheng, H Elsarraj, JT Lei, Y Hong, M Anurag, L Feng, H Kennedy, ... Breast Cancer Research 24 (1), 68, 2022 | 584 | 2022 |
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion HS Elsarraj, Y Hong, KE Valdez, W Michaels, M Hook, WP Smith, J Chien, ... Breast Cancer Research 17, 1-21, 2015 | 52 | 2015 |
A novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance HS Elsarraj, Y Hong, K Valdez, M Carletti, SM Salah, M Raimo, D Taverna, ... Journal of cell science 126 (11), 2446-2458, 2013 | 26 | 2013 |
Mouse mammary intraductal (MIND) method for transplantation of patient derived primary DCIS cells and cell lines F Kittrell, K Valdez, H Elsarraj, Y Hong, D Medina, F Behbod Bio-protocol 6 (5), e1744-e1744, 2016 | 20 | 2016 |
Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer HS Elsarraj, SR Stecklein, K Valdez, F Behbod Journal of mammary gland biology and neoplasia 17, 79-87, 2012 | 19 | 2012 |
Mouse‐INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy Y Hong, D Limback, HS Elsarraj, H Harper, H Haines, H Hansford, M Ricci, ... The Journal of pathology 256 (2), 186-201, 2022 | 16 | 2022 |
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression HS Elsarraj, Y Hong, D Limback, R Zhao, J Berger, SC Bishop, ... NPJ Breast Cancer 6 (1), 12, 2020 | 15 | 2020 |
NEMO, a transcriptional target of estrogen and progesterone, is linked to tumor suppressor PML in breast cancer HS Elsarraj, KE Valdez, Y Hong, SL Grimm, LR Ricci, F Fan, O Tawfik, ... Cancer research 77 (14), 3802-3813, 2017 | 15 | 2017 |
Role of cancer stem cells in cancer biology and therapy T Dittmar, KS Zänker CRC Press, 2013 | 15 | 2013 |
Experimental metastasis: modeling and analysis A Malek Springer Science & Business Media, 2013 | 5 | 2013 |
Metastasis from tongue squamous cell carcinoma to the kidney HS Elsarraj, S Khawar, A Hamza Autopsy & Case Reports 11, 2021 | 3 | 2021 |
Breast cancer invasion and metastasis S Stecklein, H Elsarraj, K Valdez, A Paul, F Behbod Experimental Metastasis: Modeling and Analysis, 27-56, 2013 | 2 | 2013 |
Calcifying fibrous tumor H Elsarraj, A Hamza Autopsy and Case Reports 12, e2021400, 2022 | 1 | 2022 |
Abstract P2-05-05: Expression profiling of in vivo DCIS progression models identified BCL9 as a molecular driver of invasive progression F Behbod, H Elsarraj, Y Hong, K Valdez, J Chien, A Godwin, T Fields Cancer Research 76 (4_Supplement), P2-05-05-P2-05-05, 2016 | 1 | 2016 |
The eyes don't see, what the mind doesn't know H Elsarraj, A Hamza American Journal of Clinical Pathology 158, S57, 2022 | | 2022 |
ElevatedNRASexpression as a potential driver of DCIS progression to basal-like invasive breast cancer Z Zheng, H Elsarraj, Y Hong, JT Lei, M Anurag, Y Shen, F Lo, L Feng, ... Cancer Research 82 (12_Supplement), 2979-2979, 2022 | | 2022 |
Abstract P5-01-03: Mouse-intraductal (MIND): An in vivo model for studying the underlying mechanisms of DCIS malignancy A Rastogi, J Lin, Y Hong, D Limback, HS Elsarraj, H Harper, H Haines, ... Cancer Research 82 (4_Supplement), P5-01-03-P5-01-03, 2022 | | 2022 |
Abstract PS19-15: N-RAS as a marker for DCIS progression EC Chang, Z Zheng, H Elsarraj, Y Hong, YS Shen, F Lo, L Feng, ... Cancer Research 81 (4_Supplement), PS19-15-PS19-15, 2021 | | 2021 |
Abstract PD5-09: Mouse-intraductal (MIND): The first in vivo model to recapitulate the full spectrum of human DCIS pathology F Behbod, Y Hong, D Limback, HS Elsarraj, H Harper, H Haines, ... Cancer Research 81 (4_Supplement), PD5-09-PD5-09, 2021 | | 2021 |
Abstract PD8-08: Development of humanized immune DCIS models using patient peripheral blood derived hematopoietic stem cells (CD34+) F Behbod, H Harper, H Hansford, D Limback, Y Hong, H Elsarraj, LR Ricci, ... Cancer Research 79 (4_Supplement), PD8-08-PD8-08, 2019 | | 2019 |